tiprankstipranks
Trending News
More News >
Plexus (PLXS)
NASDAQ:PLXS
Advertisement

Plexus (PLXS) AI Stock Analysis

Compare
136 Followers

Top Page

PLXS

Plexus

(NASDAQ:PLXS)

Rating:76Outperform
Price Target:
$155.00
▲(13.13% Upside)
Plexus receives a strong overall score driven by robust financial performance and positive earnings call highlights. The company's strategic investments and operational efficiency are key strengths. Technical analysis and valuation present moderate support, with the stock showing short-term bullish momentum but facing valuation challenges. The absence of a dividend yield is a minor drawback.
Positive Factors
Cash Flow
Free cash flow was better-than-expected and PLXS is on track to generate strong free cash flow in FQ4.
Financial Performance
Plexus delivered better-than-expected F3Q25 results, with in-line sales and a notable EPS beat, mainly benefited by lower interest expense and a favorable tax adjustment.
Market Share
PLXS continues to take share, and demand remains strong with new wins with three top semi-cap customers in the quarter, which is expected to support continued outperformance vs the broader industry growth.
Negative Factors
Industrial and Aerospace Markets
End-market recovery tied to industrial and aerospace has not yet materially catalyzed.
Revenue Guidance
FQ4 revenue at the midpoint of the range is expected to be down 0.5% year-over-year vs. Street +3%.

Plexus (PLXS) vs. SPDR S&P 500 ETF (SPY)

Plexus Business Overview & Revenue Model

Company DescriptionPlexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors. Plexus Corp. was founded in 1979 and is headquartered in Neenah, Wisconsin.
How the Company Makes MoneyPlexus generates revenue through a combination of contract manufacturing services, engineering services, and product development. The company's primary revenue streams include the manufacturing of electronic assemblies and systems for original equipment manufacturers (OEMs), which account for a significant portion of its earnings. Plexus also earns money by providing design and engineering services that help clients optimize product performance and manufacturability. Key partnerships with major technology companies and consistent investments in advanced manufacturing technologies enhance its competitive position and contribute to its revenue growth. Additionally, Plexus benefits from long-term contracts and relationships with clients that ensure a steady stream of business, particularly in the high-growth sectors of healthcare and industrial automation.

Plexus Earnings Call Summary

Earnings Call Date:Jul 23, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Oct 22, 2025
Earnings Call Sentiment Positive
The earnings call highlighted Plexus' strong financial performance, including record revenue and operating margin, robust free cash flow, and significant new program wins across various sectors. While there were some challenges, such as a temporary production delay in the Healthcare/Life Sciences segment and revenue pushouts in the semiconductor capital equipment subsector, the company's achievements and positive outlook for future growth significantly outweigh these issues.
Q3-2025 Updates
Positive Updates
Record Revenue and Operating Margin
Plexus achieved revenue of $1.018 billion, meeting guidance, and a non-GAAP operating margin of 6.0%, which is near the high end of guidance and an increase of 30 basis points sequentially.
Strong Free Cash Flow and Shareholder Returns
Generated $13.2 million of free cash flow, significantly better than expectations, and reduced debt while increasing share repurchase authorization.
New Program Wins and Market Expansion
Secured 41 new manufacturing programs, expected to generate $250 million in annual revenue. Expanded opportunities in European defense sector and industrial market.
High Customer Satisfaction
Achieved a 7-year high in customer satisfaction score from the Net Promoter Survey.
Positive Recognition and Sustainability Initiatives
Received recognition as one of America's greatest workplaces and released a Sustainability Report highlighting environmental initiatives.
Negative Updates
Temporary Production Delays in Healthcare/Life Sciences
A customer design update resulted in a temporary production delay, impacting the expected growth in this segment.
Pushouts in Semiconductor Capital Equipment
Experienced revenue pushouts in the semi-cap subsector, impacting the expected performance in the industrial market.
Company Guidance
During the Q3 2025 earnings call, Plexus provided guidance indicating strong financial performance, with revenue reaching $1.018 billion, which met their guidance. The company achieved a non-GAAP operating margin of 6%, which was at the high end of their guidance and a non-GAAP EPS of $1.90, exceeding expectations due to strong operating performance and favorable tax rates. For Q4 2025, Plexus forecasts revenue between $1.025 billion and $1.065 billion, a non-GAAP operating margin of 5.7% to 6.1%, and non-GAAP EPS of $1.82 to $1.97. The company also anticipates generating approximately $100 million in free cash flow for fiscal 2025 and reported $13.2 million of free cash flow in Q3, surpassing expectations. Additionally, Plexus highlighted their strategic investments that are driving organizational and operational efficiency, contributing to sustained profitability and long-term shareholder value.

Plexus Financial Statement Overview

Summary
Plexus demonstrates strong financial health with stable revenue growth, efficient profitability metrics, low leverage, and excellent cash flow generation. The company is well-positioned in its industry, but should monitor the slight decline in free cash flow to ensure sustained financial performance.
Income Statement
77
Positive
Plexus demonstrates robust revenue levels with a slight growth in revenue of 0.17% in the TTM period compared to the previous year, indicating stability. The company maintains a healthy gross profit margin of 10.1% and a net profit margin of 3.6%, reflecting efficient cost management and profitability. The EBIT margin stands at 5.0%, and the EBITDA margin is 5.9%, showing strong operational efficiency.
Balance Sheet
75
Positive
The balance sheet shows a strong equity position with an equity ratio of 43.8%, suggesting financial stability. The debt-to-equity ratio is 0.19, indicating low leverage which reduces financial risk. Return on Equity for the TTM is 10.6%, reflecting efficient use of equity to generate profits.
Cash Flow
82
Very Positive
Plexus exhibits solid cash flow performance with a significant operating cash flow to net income ratio of 2.84, indicating strong cash-generating capabilities. The free cash flow to net income ratio is 2.35, further emphasizing robust cash flow generation. However, the free cash flow growth rate is slightly negative, showing a minor decline from the previous period.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.03B3.96B4.21B3.81B3.37B3.39B
Gross Profit409.64M378.53M394.55M347.23M323.30M312.71M
EBITDA258.33M236.25M288.55M243.08M240.28M216.17M
Net Income162.68M111.81M139.09M138.24M138.91M117.48M
Balance Sheet
Total Assets3.11B3.15B3.32B3.39B2.46B2.29B
Cash, Cash Equivalents and Short-Term Investments237.57M345.11M256.23M274.81M270.17M385.81M
Total Debt174.09M279.59M469.61M495.38M291.32M371.58M
Total Liabilities1.69B1.83B2.11B2.30B1.43B1.31B
Stockholders Equity1.42B1.32B1.21B1.10B1.03B977.48M
Cash Flow
Free Cash Flow237.43M341.32M61.77M-127.85M85.48M160.28M
Operating Cash Flow310.46M436.50M165.82M-26.24M142.58M210.37M
Investing Cash Flow-72.96M-94.95M-93.30M-101.56M-56.97M-49.85M
Financing Cash Flow-199.38M-255.59M-92.72M139.29M-203.88M-1.46M

Plexus Technical Analysis

Technical Analysis Sentiment
Positive
Last Price137.01
Price Trends
50DMA
132.94
Positive
100DMA
130.56
Positive
200DMA
138.74
Negative
Market Momentum
MACD
1.79
Negative
RSI
56.97
Neutral
STOCH
91.16
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PLXS, the sentiment is Positive. The current price of 137.01 is above the 20-day moving average (MA) of 132.71, above the 50-day MA of 132.94, and below the 200-day MA of 138.74, indicating a neutral trend. The MACD of 1.79 indicates Negative momentum. The RSI at 56.97 is Neutral, neither overbought nor oversold. The STOCH value of 91.16 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PLXS.

Plexus Risk Analysis

Plexus disclosed 21 risk factors in its most recent earnings report. Plexus reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Plexus Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$6.26B25.1611.58%5.87%20.66%
79
Outperform
$4.60B50.025.89%14.24%424.78%
76
Outperform
$3.70B23.3112.12%2.31%48.63%
74
Outperform
$6.44B54.164.74%1.10%1.34%-38.02%
72
Outperform
$3.87B26.4516.49%11.33%18.47%
69
Neutral
$1.46B38.713.49%1.68%-5.95%-43.46%
61
Neutral
$35.48B7.63-10.11%1.88%8.73%-9.23%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PLXS
Plexus
137.01
14.72
12.04%
BHE
Benchmark Electronics
40.59
0.47
1.17%
LFUS
Littelfuse
259.83
5.49
2.16%
OSIS
OSI Systems
230.05
88.32
62.32%
SANM
Sanmina-Sci
117.52
50.84
76.24%
TTMI
TTM Technologies
44.57
26.45
145.97%

Plexus Corporate Events

Stock Buyback
Plexus Announces New $100 Million Share Buyback
Neutral
May 14, 2025

On May 14, 2025, Plexus Corp.’s Board of Directors approved a new share repurchase program, authorizing the buyback of up to $100 million of its common stock. This will commence after the current $50 million program, which has a remaining balance of $17.9 million as of May 13, 2025, expires. The company has not set a specific schedule for repurchases, indicating flexibility in timing and amount based on market conditions and other factors.

The most recent analyst rating on (PLXS) stock is a Buy with a $140.00 price target. To see the full list of analyst forecasts on Plexus stock, see the PLXS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 23, 2025